Histatin-5 vs Ziconotide
Head-to-head comparison of Histatin-5 (Human histatin 5) and Ziconotide (ω-Conotoxin MVIIA (ziconotide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | Ziconotide |
|---|---|---|
| Category | Dental & Oral | Pain Management |
| Full Name | Human histatin 5 | ω-Conotoxin MVIIA (ziconotide) |
| Molecular Weight | 3035 Da | 2639.1 Da |
| Half-Life | minutes in saliva | approximately 4.5 hours |
| Amino Acids | 24 | 25 |
| Typical Dose | 1-100 µM in research formulations | 0.5-19.2 mcg/day |
| Route | Topical/Oral rinse | Intrathecal |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 500 |
| Research Status | Pre-clinical | Approved |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
Ziconotide Benefits
- ✓strong non-opioid analgesia
- ✓effective for refractory neuropathic pain
- ✓opioid-sparing option
- ✓intrathecal delivery allows targeted action
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
Ziconotide Dosing
start 0.5 mcg/day intrathecal|titrate by 0.5 mcg/day no more than 2 times weekly|max 19.2 mcg/day in labeling
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
Ziconotide Side Effects
- ⚠dizziness
- ⚠confusion
- ⚠ataxia
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
Ziconotide
Clinical studies and post-marketing data support ziconotide as an analgesic for severe chronic pain that does not respond to conventional therapy. Research focuses on balancing analgesic efficacy with neuropsychiatric tolerability and careful dose titration.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.